David Shaw’s Universal Health Services UHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-7,800
Closed -$1.13M – 5793
2022
Q1
$1.13M Hold
7,800
– – ﹤0.01% 3805
2021
Q4
$1.01M Buy
+7,800
New +$1M ﹤0.01% 3923
2018
Q1
– Sell
-2,900
Closed -$329K – 3786
2017
Q4
$329K Buy
+2,900
New +$310K ﹤0.01% 3200
2016
Q1
– Sell
-29,100
Closed -$3.48M – 3794
2015
Q4
$3.48M Hold
29,100
– – 0.01% 1700
2015
Q3
$3.63M Hold
29,100
– – 0.01% 1639
2015
Q2
$4.14M Buy
+29,100
New +$3.64M 0.01% 1609
2015
Q1
– Sell
-20,500
Closed -$2.28M – 4042
2014
Q4
$2.28M Sell
20,500
-16,800
-45% -$1.76M ﹤0.01% 2169
2014
Q3
$3.9M Buy
37,300
+13,700
+58% +$1.46M 0.01% 1738
2014
Q2
$2.26M Buy
+23,600
New +$2.04M ﹤0.01% 2216
2014
Q1
– Sell
-80,000
Closed -$6.5M – 4636
2013
Q4
$6.5M Hold
80,000
– – 0.01% 1466
2013
Q3
$6M Hold
80,000
– – 0.01% 1436
2013
Q2
$5.36M Buy
+80,000
New +$5.29M 0.01% 1308

Other funds holding UHS

David Shaw's UHS Position: Q3 2026 in Review

David Shaw reduced its Universal Health Services (UHS) stake by 68% in Q3 2026, selling an estimated $16.6M and leaving 46,188 shares worth $8.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2005.

David Shaw first reported a position in UHS in Q2 2013 and has held it in 50 quarters since. The position peaked at $104M in Q2 2017. 636 funds tracked by Wall St. Rank hold UHS as of Q3 2026.

  • David Shaw held 46,188 shares of Universal Health Services worth $8.05M as of Q3 2026.
  • David Shaw sold 99,062 Universal Health Services shares in Q3 2026, an estimated $16.6M.
  • Universal Health Services made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #2005 holding.
  • David Shaw first reported a position in Universal Health Services in Q2 2013 and has held it in 50 quarters since.
  • David Shaw's Universal Health Services position peaked at $104M in Q2 2017.
  • 636 funds tracked by Wall St. Rank held Universal Health Services as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.